Search Within

Dmitriy Zamarin

  1. "Taha Merghoub"
Formats
  1. Journal Article (17)
  2. Meeting Abstract (15)
  3. Guidelines (1)
Groups
  1. Department of Medicine (33)
  2. GDMT, Medicine (33)
  3. Gynecologic Medicine Service (33)
  4. Gynecology Disease Management Team (33)
  5. Melanoma and Immunotherapeutics Service (33)
  6. Solid Tumor Oncology Division (33)

More Groups

People
  1. Taha Merghoub (33)
  2. Jedd Wolchok (28)
  3. Jacob Ricca (11)
  4. Rikke Holmgaard (9)
  5. Mathieu Gigoux (8)
  6. Cailian Liu (7)

More People

Years
  1. 2023 (2)
  2. 2022 (3)
  3. 2021 (2)
  4. 2020 (5)
  5. 2019 (1)
  6. 2018 (5)

More Years

Publications
  1. Journal for ImmunoTherapy of Cancer (9)
  2. Cancer Immunology Research (3)
  3. Cell (2)
  4. Gynecologic Oncology (2)
  5. Nature Communications (2)
  6. Advances in Cancer Research (1)

More Publications

Publishers
  1. Biomed Central Ltd (9)
  2. American Association for Cancer Research (5)
  3. Cell Press (4)
  4. Nature Publishing Group (4)
  5. Elsevier Inc. (3)
  6. Academic Press, Elsevier Inc (1)

More Publishers

Results (33)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Blockade of AHR activation by IDO/TDO-derived kynurenine restricts cancer immune suppression
    Meeting Abstract

    Campesato, L. F.; Budhu, S.; Gigoux, M.; Tchaicha, J.; Pourpe, S.; Liu, C.; Zamarin, D.; Manfredi, M. G.; McGovern, K.; Wolchok, J. D.; more...
    Cancer Immunology Research (2020)

    Fulltext@MSK | Save
  • Consensus guidelines for the definition, detection and interpretation of immunogenic cell death
    Guidelines

    Galluzzi, L.; Vitale, I.; Warren, S.; Adjemian, S.; Agostinis, P.; Martinez, A. B.; Chan, T. A.; Coukos, G.; Demaria, S.; Deutsch, E.; more...
    Journal for ImmunoTherapy of Cancer (2020)

    Fulltext@MSK | Save
  • Blockade of IDO/TDO downstream effectors restricts a Treg-macrophage suppressive axis and resistance to anti-PD-1 therapy
    Meeting Abstract

    Campesato, L.; Budhu, S.; Tchaicha, J.; Gigoux, M.; Cohen, I.; Mangarin, L.; Redmond, D.; Pourpe, S.; Liu, C.; Zappasodi, R.; more...
    Journal for ImmunoTherapy of Cancer (2019)

    Fulltext@MSK | Save
  • Immune-active microenvironment in small cell carcinoma of the ovary, hypercalcemic type: Rationale for immune checkpoint blockade
    Journal Article

    Jelinic, P.; Ricca, J.; Van Oudenhove, E.; Olvera, N.; Merghoub, T.; Levine, D. A.; Zamarin, D.
    JNCI: Journal of the National Cancer Institute (2018)

    Fulltext@MSK | Save
  • Immune-active microenvironment in SCCOHT: Rationale for therapy with immune checkpoint blockade
    Meeting Abstract

    Van Oudenhove, E.; Jelinic, P.; Ricca, J.; Olvera, N.; Merghoub, T.; Levine, D. A.; Dmitriy, Z.
    Clinical Cancer Research (2018)

    Fulltext@MSK | Save
  • Lysis-independent potentiation of immune checkpoint blockade by oncolytic virus
    Journal Article

    Oseledchyk, A.; Ricca, J. M.; Gigoux, M.; Ko, B.; Redelman-Sidi, G.; Walther, T.; Liu, C.; Iyer, G.; Merghoub, T.; Wolchok, J. D.; more...
    Oncotarget (2018)

    Fulltext@MSK | Save
  • Pre-existing immunity to oncolytic virus potentiates its immunotherapeutic efficacy
    Journal Article

    Ricca, J. M.; Oseledchyk, A.; Walther, T.; Liu, C.; Mangarin, L.; Merghoub, T.; Wolchok, J. D.; Zamarin, D.
    Molecular Therapy (2018)

    Fulltext@MSK | Save
  • PD-L1 in tumor microenvironment mediates resistance to oncolytic immunotherapy
    Journal Article

    Zamarin, D.; Ricca, J. M.; Sadekova, S.; Oseledchyk, A.; Yu, Y.; Blumenschein, W. M.; Wong, J.; Gigoux, M.; Merghoub, T.; Wolchok, J. D.
    Journal of Clinical Investigation (2018)

    Fulltext@MSK | Save
  • Intratumoral delivery of inactivated modified vaccinia virus Ankara (iMVA) induces systemic antitumor immunity via STING and Batf3-dependent dendritic cells
    Journal Article

    Dai, P.; Wang, W.; Yang, N.; Serna-Tamayo, C.; Ricca, J. M.; Zamarin, D.; Shuman, S.; Merghoub, T.; Wolchok, J. D.; Deng, L.
    Science Immunology (2017)

    Fulltext@MSK | Save
  • Upregulation of PD-L1 in tumor microenvironment is a resistance mechanism for oncolytic virus immunotherapy
    Meeting Abstract

    Zamarin, D.; Ricca, J.; Oseledchyk, A.; Gigoux, M.; Merghoub, T.; Wolchok, J.
    Journal for ImmunoTherapy of Cancer (2017)

    Fulltext@MSK | Save